Furthermore, Chen et al. (2010), Yagihashi et al. (2005), and Wu et al. (2014) have independently identified anti-BIRC5 autoantibody as a promising marker for colorectal cancer, breast cancer, and oral cancer through single-stage validation. Here, BIRC5 is linked to lip and oral cavity carcinoma.